Risk factors for the development of freezing of gait in Parkinson’s disease patients

The risk factors that influence the development of freezing of gait or FOG.

Novel findings on GRB2 and SOS1 could pave the way for cancer treatments

Researchers from Tokyo Metropolitan University have uncovered new insights into how the proteins GRB2 and SOS1 in cells pass signals from membrane receptors to nuclei.

October 27, 2024

Q&A: Amid AI frenzy in medicine, a federal regulator’s quest to create safeguards

Micky Tripathi is equal parts excited — and deeply concerned — about the technological change sweeping through medicine. As adoption of generative AI races ahead,

March 14, 2024

Argenx scraps program in skin autoimmune disease after Vyvgart Hytrulo flunks another PhIII trial

Argenx’s autoimmune disease drug Vyvgart Hytrulo flunked its second late-stage trial in as many months, and the company is abandoning the indication altogether. The Dutch

December 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.